Literature DB >> 3370192

The effect of probenecid on the renal tubular excretion of benzylpenicillin.

D Overbosch1, C Van Gulpen, J Hermans, H Mattie.   

Abstract

1 The aim of this study was to establish whether the renal tubular excretion of benzylpenicillin is saturable and whether the effect of probenecid on the tubular excretion of benzylpenicillin is dose-dependent. 2 Each of four volunteers underwent three experiments. In each experiment benzylpenicillin was administered by continuous infusion, such that three different consecutive concentration levels were reached. In the first experiment no probenecid was given; in the second and third experiments, probenecid was administered by continuous infusion at a low and higher rate, respectively. 3 Plasma and urinary concentrations of benzylpenicillin were determined at 30 min intervals by high performance liquid chromatography. 4 By fitting the equation Rtub = Rtub,max.Cp/(EC50 + Cp) to the values of the tubular excretion rate found for benzylpenicillin (Rtub) vs the free plasma concentration (Cp), the values of Rtub,max and EC50 could be calculated: 3350 (+/- 606) mg h-1 for Rtub,max and 48.0 (+/- 17.8) mg l-1 for EC50 (in the absence of probenecid). 5 The EC50 for benzylpenicillin increased significantly with increasing doses of probenecid. 6 The dose of probenecid at which 50% of the excretory system is occupied by probenecid in the absence of benzylpenicillin (ED50) ranged from 13.2 to 108.5 mg h-1. 7 The EC50 of probenecid in one subject could actually be measured: 52.3 mg l-1. 8 Extrapolating these results to the clinical situation, the commonly used daily dose of 2 g of probenecid is likely to be close to the maximal effective dose for inhibition of the tubular excretion of benzylpenicillin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370192      PMCID: PMC1386614          DOI: 10.1111/j.1365-2125.1988.tb03281.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material.

Authors:  P G DAYTON; T F YU; W CHEN; L BERGER; L A WEST; A B GUTMAN
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

2.  Enzymatic factors in renal tubular secretion of phenol red.

Authors:  K H BEYER; R H PAINTER; V D WIEBELHAUS
Journal:  Am J Physiol       Date:  1950-05

3.  THE PROLONGATION OF PENICILLIN RETENTION IN THE BODY BY MEANS OF PARA-AMINOHIPPURIC ACID.

Authors:  K H Beyer; R Woodward; L Peters; W F Verwey; P A Mattis
Journal:  Science       Date:  1944-08-04       Impact factor: 47.728

4.  Saturation of the tubular excretion of beta-lactam antibiotics.

Authors:  J W Bins; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

5.  Observations on the disposition of probenecid in patients receiving allopurinol.

Authors:  T B Tjandramaga; S A Cucinell; Z H Israili; J M Perel; P G Dayton; T F Yü; A B Gutman
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

6.  Penicillin-induced seizures during cardiopulmonary bypass. A clinical and electroencephalographic study.

Authors:  K B Seamans; P Gloor; R A Dobell; J D Wyant
Journal:  N Engl J Med       Date:  1968-04-18       Impact factor: 91.245

7.  Penicillin handling in normal and azotemic patients.

Authors:  M E Plaut; C J O'Connell; R C Pabico; D Davidson
Journal:  J Lab Clin Med       Date:  1969-07

8.  Renal clearance of temocillin in volunteers.

Authors:  D Overbosch; C van Gulpen; H Mattie
Journal:  Drugs       Date:  1985       Impact factor: 9.546

9.  Penicillin neurotoxicity.

Authors:  P I Lerner; H Smith; L Weinstein
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

Review 10.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

View more
  8 in total

Review 1.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

2.  Towards longitudinal mapping of extracellular pH in gliomas.

Authors:  Yuegao Huang; Daniel Coman; Peter Herman; Jyotsna U Rao; Samuel Maritim; Fahmeed Hyder
Journal:  NMR Biomed       Date:  2016-07-29       Impact factor: 4.044

3.  Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices.

Authors:  Chutima Srimaroeng; Promsuk Jutabha; John B Pritchard; Hitoshi Endou; Varanuj Chatsudthipong
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

4.  The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.

Authors:  C A Verhagen; H Mattie; E Van Strijen
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of aztreonam.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

6.  Inhibition of flucloxacillin tubular renal secretion by piperacillin.

Authors:  Cornelia B Landersdorfer; Carl M J Kirkpatrick; Martina Kinzig; Jürgen B Bulitta; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Br J Clin Pharmacol       Date:  2008-11       Impact factor: 4.335

Review 7.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

Review 8.  Review of Urate-Lowering Therapeutics: From the Past to the Future.

Authors:  Christopher Jenkins; Jennifer H Hwang; Jeffrey B Kopp; Cheryl A Winkler; Sung Kweon Cho
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.